- Home
- KROS vs FC Comparison
KROS vs FC Comparison
Compare KROS & FC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KROS | FC |
|---|---|---|
| Founded | 2015 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 206.0M | 202.8M |
| IPO Year | 2020 | 1994 |
Fundamental Metrics
Financial Performance| Metric | KROS | FC |
|---|---|---|
| Price | $12.02 | $18.21 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | $19.83 | ★ $31.00 |
| AVG Volume (30 Days) | ★ 173.6K | 41.4K |
| Earning Date | 11-04-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 146.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $243,864,000.00 | ★ $267,067,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.19 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.69 | $11.16 |
| 52 Week High | $22.55 | $26.81 |
Technical Indicators
Market Signals| Indicator | KROS | FC |
|---|---|---|
| Relative Strength Index (RSI) | 60.83 | 52.56 |
| Support Level | $10.12 | $16.12 |
| Resistance Level | $12.65 | $20.85 |
| Average True Range (ATR) | 0.52 | 0.51 |
| MACD | 0.02 | 0.23 |
| Stochastic Oscillator | 82.41 | 84.67 |
Price Performance
Historical ComparisonAbout KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About FC Franklin Covey Company
Franklin Covey Co is a company focused on organizational performance improvement. It operates in the business segments of North America, International Direct Offices, International Licensees, Education Division. The company derives revenue from providing training and consulting services and through the sale of books, audio media, and other related products. It has a business presence in Australia, New Zealand, China, Japan, the United Kingdom, Ireland, and Other countries.